Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

International Nursing Organizations II01:28

International Nursing Organizations II

1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
Primary Healthcare Services01:30

Primary Healthcare Services

1.7K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.7K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

333
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
333
Global Regulatory Systems01:28

Global Regulatory Systems

252
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
252
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

932
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
932
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial-resistant <i>E. coli</i> in human, animal and environmental reservoirs in rural Bangladeshi households with young children.

medRxiv : the preprint server for health sciences·2026
Same author

Glucagon-like peptide-1 receptor agonists as a metabolic optimization strategy in surgical prehabilitation: a translational perspective.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026
Same author

Lowering the Barrier to Surgical Research: Can Artificial Intelligence (AI) Support Trainees?

ANZ journal of surgery·2026
Same author

European Society of Clinical Pharmacy: bridging gaps-clinical pharmacy in the digital transition of care.

International journal of clinical pharmacy·2026
Same author

From public healthcare centers to community pharmacies: the new Portuguese seasonal vaccination strategy.

Frontiers in public health·2026
Same author

Molecular basis of competence for neural induction in the chick embryo.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Nov 5, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.3K

Structured Multi-Stakeholder Workshops to Advance a Global Transformative Roadmap for Pharmaceutical Workforce.

Andreia Bruno1, Lina Bader2, Ian Bates3

  • 1Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.

Innovations in Pharmacy
|May 19, 2021
PubMed
Summary
This summary is machine-generated.

The International Pharmaceutical Federation (FIP) held workshops to develop a pharmaceutical workforce roadmap. Key findings emphasize collaboration and standardized terminology to overcome implementation challenges and achieve workforce development goals.

Keywords:
pharmaceutical educationpharmaceutical workforce development goalspharmacy educationroadmaptransformative education

More Related Videos

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

570
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.5K

Related Experiment Videos

Last Updated: Nov 5, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.3K
Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
06:22

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform

Published on: July 29, 2025

570
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.5K

Area of Science:

  • Pharmaceutical Workforce Development
  • Global Health Policy
  • Pharmacy Education

Background:

  • The International Pharmaceutical Federation (FIP) initiated a project in 2016 to create a shared vision for a transformative pharmaceutical workforce roadmap.
  • Three milestone documents were developed and presented at the Global Conference on Pharmacy and Pharmaceutical Education.
  • Workshops were conducted to analyze key themes and connect with Pharmaceutical Workforce Development Goals (PWDG).

Purpose of the Study:

  • To summarize key aspects of the FIP workshops.
  • To report on innovative approaches used to generate guidance for stakeholders regarding implementation of the pharmaceutical workforce roadmap.
  • To analyze drivers, challenges, and strategies for implementing the Pharmaceutical Workforce Development Goals (PWDG).

Main Methods:

  • Seven workshops with a uniform structure were conducted to improve communication and aggregate analysis.
  • Each workshop was led by a team of seven (Chair, facilitator, rapporteur, four speakers) selected from FIP member organizations and stakeholders.
  • Guidelines and templates were developed for all roles, and teams received advance briefings.

Main Results:

  • Approximately 200 participants attended the seven workshops, representing all six World Health Organization regions.
  • Key aspects explored included drivers (enhancing collaboration), challenges (variance in terminology), and strategies (communication, advocacy, best practices) for implementation.
  • Enhancing collaboration and engagement were identified as key drivers for workforce transformation.

Conclusions:

  • The unique workshop format, inclusive stakeholder engagement, and parallel structure yielded reliable findings.
  • Achievability of the PWDGs is contingent upon stakeholder engagement and collaboration among professional associations.
  • Effective communication strategies and advocacy are crucial for successful workforce development.